doi: 10.1016/j.arr.2023.101978 82 KumariS.KumaranS.GoyalV.SharmaR
CONTENTS OF THE PACK AND OTHER INFORMATION WHAT HYDROXOCOBALAMINE INJECTION CONTAINS The active substance is Hydroxocobalamin
Dellis, A., & Papatsoris, A
Based on this review, in the CY 2026 OPPS/ASC proposed rule we stated that we believed it would be appropriate to propose the use of hospitals' median payer-specific negotiated charges for MAOs, to be collected on the Medicare cost report as described previously, within a proposed new methodology for calculating the MS-DRG relative weights to reflect a more market-based approach, using our authority under sections 1886(d)(4)(A), 1886(d)(4)(B), and 1886(d)(4)(C) of the Act
For comparison within the groups before and after treatment, we used the paired t test
Handled as an oral, sublingual or transdermal preparation in research settings